Development of multiple mouse models with deletion or mutations in Brca1 targeted to the mammary gland has provided an opportunity to examine the biology and therapeutic implications of BRCA1 loss in breast cancer [15] and some studies find similarities between the mouse and human tumors [11,16,17]. The gene discussed is BRCA1; the disease is breast carcinoma.